We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blocking ITK Activity Slows Growth of Malignant Melanoma in Mouse Model

By LabMedica International staff writers
Posted on 13 May 2015
Print article
Image: Molecular model of IL2 inducible T-cell kinase (ITK) enzyme (Photo courtesy of Wikimedia Commons).
Image: Molecular model of IL2 inducible T-cell kinase (ITK) enzyme (Photo courtesy of Wikimedia Commons).
Development of malignant melanoma was found to depend to some extent on the activity of the enzyme produced by the gene interleukin-2 (IL2) inducible T-cell kinase (ITK).

Investigators at the University of North Carolina (Chapel Hill, USA) used an ITK-specific monoclonal antibody to probe sections from formalin-fixed paraffin-embedded tumor blocks or melanoma cell line arrays. ITK was visualized by immunohistochemistry (IHC).

Results published in the May 1, 2015, issue of the journal Clinical Cancer Research revealed that ITK was expressed at greater levels in primary and metastatic melanomas than in non-cancerous moles. In metastatic melanoma samples, 91% had higher expression levels than of the non-cancerous moles.

Treatment of melanoma-bearing mice with a low molecular weight ITK inhibitor reduced growth of ITK-expressing xenografts or established native melanomas.

“We have discovered that ITK is highly expressed in melanoma even though it was thought to be restricted to immune cells, and when you inhibit it, you decrease melanoma growth,” said senior author Dr. Nancy E. Thomas, professor of dermatology at the University of North Carolina. “Therefore, we think it is a good potential drug target.”

Related Links:
University of North Carolina


New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.